ArticleCancer reports (Hoboken, N.J.)2021

A cost-utility analysis of avelumab for metastatic Merkel cell carcinoma in Taiwan.

Wen-Cheng Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.